Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0000950170-24-064820

Director acquired 10,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KARBE FRANK Director 2024-05-23 Grant or award +10,500 19,500 D
Derivatives
KARBE FRANK Director 2024-05-23 Grant or award · Stock Option (Right to Buy) −17,500 17,500 D
Loading xslF345X05/ownership.xml…